Showing 41-50 of 2822 results for "".
Factors Influencing the Selection of CSF Tests for Alzheimer Disease
https://practicalneurology.com/videos/neurology-in-motion/factors-influencing-the-selection-of-csf-tests-for-alzheimer-disease/35726/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses key factors influencing the selection of cerebrospinal fluid tests for Alzheimer disease.Ocrevus Treatment in Pregnant and Lactating Women with Multiple Sclerosis
https://practicalneurology.com/programs/practical-neurology/ocrevus-treatment-pregnant-lactating-women-with-multiple-sclerosis/35558/Riley Bove, MD, UCSF School of Medicine, San Francisco, CA details results from the MINORE and SOPRANINO studies examining Ocrevus treatment in pregnant and lactating women with multiple sclerosis.Factors Influencing the Selection of Amyloid PET Tests for Alzheimer Disease
https://practicalneurology.com/videos/neurology-in-motion/factors-influencing-the-selection-of-amyloid-pet-tests-for-alzheimer-disease/37135/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses key factors influencing the selection of amyloid PET tests for Alzheimer disease.Narcolepsy, Idiopathic Hypersomnia, and General Sleep Disorders
https://practicalneurology.com/programs/practical-neurology/narcolepsy-idiopathic-hypersomnia-and-general-sleep-disorders/30083/In this episode, Rajkumar Dasgupta, MD, Clinical Associate Professor at Keck School of Medicine of USC and sleep specialist, provides an in-depth review of what's new in sleep disorders, with a special focus on updates in narcolepsy and idiopathic hypersomnia.Diagnosis and Management of Dementia and Psychosis in Individuals With Parkinson Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/diagnosis-and-management-of-dementia-and-psychosis-in-individuals-with-parkinson-disease/39935/Jorge Patino, MD, Movement Disorders Fellow, University of Cincinnati, Cincinnati, OH, provides an overview of dementia and psychosis in people with Parkinson disease, including clinical approaches for the diagnosis of these conditions, and nonpharmacologic, environmental, and pharmacologic treatmenHow to Communicate the Results of Alzheimer Disease Biomarker Tests with Patients
https://practicalneurology.com/videos/neurology-in-motion/how-to-communicate-the-results-of-alzheimer-disease-biomarker-tests-with-patients/39733/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses how to communicate the results of Alzheimer disease biomarker tests with patients.Factors Influencing the Selection of Blood Tests for Alzheimer Disease
https://practicalneurology.com/videos/neurology-in-motion/factors-influencing-the-selection-of-blood-tests-for-alzheimer-disease/39224/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses key factors influencing the selection of blood tests for Alzheimer disease.Cerebrovascular Inflammatory Conditions: Diagnostic Challenges and Treatment Considerations
https://practicalneurology.com/diseases-diagnoses/stroke/cerebrovascular-inflammatory-conditions-diagnostic-challenges-and-treatment-considerations/36478/Abbas Kharal, MD, MPH, Neurologist at Cleveland Clinic Neurological Institute, Cleveland, OH, provides a review of cerebrovascular inflammatory conditions, with an emphasis on diagnostic challenges, the evolving treatment landscape, and the use of imaging and clinical responses to assist cliniciansA Fisherman Who Can Not Peel Shrimp Any More
https://practicalneurology.com/diseases-diagnoses/neuromuscular/a-fisherman-who-can-not-peel-shrimp-any-more/31081/A 21-year-old shrimp peeler developed weakness of his fingers five years earlier that progressed to a degree that was not compatible with his job. He had no neck pain, arm numbness, dysphagia or muscle twitching. Family history was not relevant. Examination is shown. CPK was 530 U/L and EMG revealedSeeking Breakthroughs: The Startup Perspective
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-startup-perspective/30194/A roundtable discussion with Chase Spurlock, PhD, IQuity; Michal Izrael, PhD, Kadimastem Ltd; Kevin Hrusovsky, Quanterix; and J. Michael Ryan, MD, Rodin Therapeutics